文献速递鼻科头颈外科

非甾体抗炎药用于鼻窦手术术后镇痛获益与风险:系统综述与Meta分析

The benefits and risks of non-steroidal anti-inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta-analysis.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-02-28

该研究检索MEDLINE、EMBASE、Cochrane CENTRAL、CINAHL及WHO ICTRP至2022年1月27日,纳入15项随机对照试验(1210例患者)及2项观察性研究,评估非甾体抗炎药(NSAIDs)在鼻窦手术术后镇痛中的疗效与安全性。结果显示,内镜下鼻窦手术后NSAIDs组与非NSAIDs组疼痛评分无差异,鼻整形术后NSAIDs降低疼痛评分,总体减少补救镇痛需求,并降低恶心风险,且未增加鼻出血风险。

要点

  • 内镜下鼻窦手术后NSAIDs与非NSAIDs组疼痛评分无差异(SMD 0.44单位,95%CI -0.18至1.05)。
  • 鼻整形术后NSAIDs较非NSAIDs方案降低疼痛评分(SMD 1.14单位,95%CI 0.61至1.67)。
  • NSAIDs总体减少补救镇痛需求(RR 0.45,95%CI 0.24至0.84),降低恶心风险(RR 0.62,95%CI 0.42至0.91),未增加鼻出血风险(RR 0.72,95%CI 0.23至2.22)。

核心结论

  • 在鼻窦手术患者中,NSAIDs有利于术后疼痛管理并避免术后恶心,且不增加术后鼻出血风险。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、Cochrane Central Register of Controlled Trials、CINAHL及WHO International Clinical Trials Registry Platform,检索时间从建库至2022年1月27日,纳入随机对照试验和比较性观察性研究,不限语言,筛选、数据提取和偏倚风险评估由两人重复进行。
  • 共纳入4661条记录中筛选出的15项随机对照试验(入组1210例患者)和2项观察性研究。

主要发现

  • 内镜下鼻窦手术后,NSAIDs组与非NSAIDs组疼痛评分无差异(标准化均数差[SMD] 0.44单位,95%CI -0.18至1.05)。
  • 鼻整形术后,NSAIDs组较非NSAIDs方案降低疼痛评分(SMD 1.14单位,95%CI 0.61至1.67单位)。
  • 总体而言,NSAIDs减少补救镇痛需求,相对风险(RR)为0.45(95%CI 0.24至0.84)。
  • NSAIDs降低恶心风险,RR为0.62(95%CI 0.42至0.91),且未增加鼻出血风险(RR 0.72,95%CI 0.23至2.22)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) have emerged as an alternative to opioids for optimal postoperative pain management. However, the adoption of NSAIDs in sinonasal surgery has been impeded by a theoretical concern for postoperative bleeding. Our objective is to systematically review the efficacy and safety of NSAIDs for patients undergoing sinonasal surgery. METHODS: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO International Clinical Trials Registry Platform were searched from inception to January 27, 2022. Randomized controlled trials (RCTs) and comparative observational studies in any language were considered. Screening, data extraction, and risk of bias assessment were performed in duplicate. Our outcomes were postoperative pain scores, requirement for rescue analgesia, and postoperative adverse events (epistaxis, nausea/vomiting). RESULTS: Out of 4661 records, 15 RCTs (enrolling 1210 patients) and two observational studies were included. Following endoscopic sinus surgery, there was no difference in pain scores between NSAIDs and non-NSAIDs groups (standardized mean differences [SMD] 0.44 units better, 95% CI -0.18 to 1.05). Following septorhinoplasty, NSAIDs decreased pain scores compared to non-NSAID regimens (SMD 1.14 units better, 95% CI 0.61 to 1.67 units better). Overall, NSAIDs reduced the need for rescue medication with a relative risk (RR) of 0.45 (95% CI 0.24 to 0.84). In addition, NSAIDs decreased the risk of nausea with an RR of 0.62 (95% CI 0.42 to 0.91) and did not increase the risk of epistaxis (RR 0.72, 95% CI 0.23-2.22). CONCLUSION: Among patients undergoing sinonasal surgery, NSAIDs are beneficial in postoperative pain management and avoidance of postoperative nausea without increasing the risk of postoperative epistaxis.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Lee DJ, Grose E, Brenna CTA, et al. The benefits and risks of non-steroidal anti-inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2023. PMID: 36762711. doi:10.1002/alr.23140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。